“We believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate about transforming patients’ lives.”


Genentech is a leading biotechnology company dedicated to providing innovative medical solutions through advanced technology and genetic engineering. Based in San Francisco, California, they are considered one of the pioneers of biotechnology. The are members of the Roche Group, a multinational health care company that specializes in pharmaceuticals and diagnostics.

Genentech’s work spans a variety of subject matters, including biooncology, immunology, virology, primary care and neurology.


Genentech was founded in 1976 as a joint venture between venture capitalist Robert A. Swanson and biochemist Dr. Herbert W. Boyer. The company was established after Swanson expressed interest in a new scientific field of study developed by Boyer and geneticist Stanley Cohen. That field? Recombinant DNA technology.

In 1990, Genentech was bought by Roche Holding Ltd. after the company acquired a majority holding of Genentech. The company opened their “Founders Research Center” in 1992, which was dedicated to Swanson and Boyer for their passion and pursuit of biotechnological knowledge.

In 2016, the company celebrated its 40th anniversary.


  • Ocrevus – also known as ocrelizumab, this is an intravenous medication for adults suffering from relapsing or progressive forms of multiple sclerosis. This injection is an antibody that is directed against a particular type of B-cells.
  • Tamiflu – also known as oseltamivir phosphate, is a prescription medication used to treat the flu (influenza). This medication is used in people over 2 weeks of age and older who have had symptoms of the flu for no longer than two days. It is not a substitute for the flu vaccine.
  • Valium – a particular brand of diazepam, is a type of benzodiazepine that works as a sedative, muscle-relaxer and anxiety-reducing medication. It is recommended to take the bare minimum if you are prescribed Valium, as it can lead to abuse and addiction.

Lehigh Center for Clinical Research

Who We Are

Lehigh Center works with companies like Genentech to share data and knowledge pertaining to neurological conditions to learn how to best treat our patients.

Our clinical trials are offered for many conditions, including Alzheimer’s Disease, Bipolar Disorder, Depression and Schizophrenia. If you’re interested in one of our trials but you don’t qualify for any that are currently listed, you can leave your information and be considered for a future study.